Home › Funds › Qube Research & Technologies Ltd › INSM
Qube Research & Technologies Ltd position in INSM
INSMED INC · Health Care
Qube Research & Technologies Ltd reported holding 1,682,334 shares of INSM (INSMED INC) in its Q2 2026 13F filing — a position valued at US$179.4M, representing 0.35% of its reported portfolio and ranking #40 among its reported holdings. Qube Research & Technologies Ltd has disclosed INSM holdings in 8 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Qube Research & Technologies Ltd's INSM position evolved
Qube Research & Technologies Ltd first disclosed a stake in INSM in Q4 2023 at 20,397 shares (US$632K). The position peaked in Q3 2025 at 1,544,315 shares, worth US$222.4M. Across 8 filings, Qube Research & Technologies Ltd increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,682,334 shares valued at US$179.4M — an increase of 1,533,819 shares quarter over quarter.. Notable position changes include a 64% increase in Q1 2024 (shares rose 147% over the following quarter), a 43% increase in Q3 2025 (shares rose 24% over the following quarter), a 1033% increase in Q2 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 20.40K | $632.10K | New |
| Q1 2024 | 33.50K | $908.86K | Add |
| Q3 2024 | 489.31K | $35.72M | New |
| Q4 2024 | 389.03K | $26.86M | Reduce |
| Q2 2025 | 1.08M | $108.90M | New |
| Q3 2025 | 1.54M | $222.40M | Add |
| Q1 2026 | 148.51K | $24.29M | New |
| Q2 2026 | 1.68M | $179.37M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INSM and 13F data
INSM (INSMED INC) is a Health Care company. 39 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$937.8M), Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INSM
- BAKER BROS. ADVISORS LP 8.80M sh · $937.84M · Q2 2026
- Darwin Global Management, Ltd. 6.43M sh · $673.60M · Q2 2026
- Orbis Allan Gray Ltd 6.08M sh · $647.88M · Q2 2026
- D. E. Shaw & Co 5.94M sh · $633.12M · Q2 2026
- Artisan Partners Limited Partnership 5.44M sh · $580.20M · Q2 2026
- RTW INVESTMENTS, LP 4.84M sh · $516.35M · Q2 2026
- Maverick Capital 2.15M sh · $229.31M · Q2 2026
- MAVERICK CAPITAL LTD 2.15M sh · $229.31M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.63M sh · $173.74M · Q2 2026
- Integral Health Asset Management, LLC 1.60M sh · $170.59M · Q2 2026
- Bellevue Group AG 1.39M sh · $148.57M · Q2 2026
- Duquesne Family Office LLC 1.35M sh · $143.94M · Q2 2026
More on Qube Research & Technologies Ltd
FAQ
How long has Qube Research & Technologies Ltd held INSM?
Qube Research & Technologies Ltd has disclosed INSM holdings in 8 of the last 11 reported quarters, going back to Q4 2023.
What is Qube Research & Technologies Ltd's current position in INSM?
As of Q2 2026, Qube Research & Technologies Ltd holds 1.68M shares of INSM (INSMED INC), valued at $179.37M, representing 0.35% of its reported portfolio and ranking #40.
Has Qube Research & Technologies Ltd been buying or selling INSM?
In the latest 13F filing (Q2 2026), Qube Research & Technologies Ltd increased its position in INSM. The position peaked in Q3 2025 at 1.54M shares.
Which other funds hold INSM?
Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Darwin Global Management, Ltd., Orbis Allan Gray Ltd, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.